Leaders accross industries have high expectations from Prime Minister Narendra Modi. As the new government gets down to business, Express Pharma asks key industry leaders to shortlist the top priority areas for policy change and infrastructure inputs
– Ranjit Shahani, Vice Chairman and Managing Director, Novartis India
– Daara B Patel, Secretary-General, IDMA
– Kiran Mazumdar Shaw, Chairman and Managing Director, Biocon
– Dr Ajit Dangi, President and CEO, Danssen Consulting
– Rajesh Desai, Executive Director – Finance, Glenmark Pharma
– BR Sikri, Vice President, BDMA, Vice President, IDMA
– S V Veerramani, President, IDMA
– John J Castellani, President and Chief Executive Officer, PhRMA
– Dr Viraj Rajadhyaksha, Asia Area Medical Affairs Manager, AstraZeneca
– Ranjana Smetacek Director General, OPPI
– DA Prasanna, Chairman, ACRO India
